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Brief Report 
An Unusua l  Reaction to Opioid Blockade 
with Naltrexone in a Case of 
Post-Traumatic  Stress Disorder 
Paloma Ibarra 1,2 Stephen P. Bruehl,  1,2 James  A. McCubbin,  1,4 
Charles R. Carlson,  2 John F. Wilson,  I Jane A. Norton,  1 
and T h o m a s  B. Montgomery  3 
An unusual behavioral and cardiovascular reaction was observed during opioid 
blockade with naltrexone in a 32-year-old male who met DSM III-R criteria 
for  pos t - t raumat ic  stress disorder (PTSD).  As  par t  o f  an ongoing 
placebo-controlled investigation o f  the effects o f  naltrexone on laboratory and 
ambulatory blood pressure reactivity, this participant reported experiencing 
feelings of  rage, explosive behavior, and other unpleasant symptoms. When 
compared to all other subjects (N = 24), this individual showed significantly 
greater effects o f  naltrexone on blood pressure reactivity during the laboratory 
stressor. His ambulatory blood pressures, when compared to placebo, were 
significantly increased during the 24-hr period following naltrexone. The 
unusual behavioral and cardiovascular responses following ingestion o f  
naltrexone suggest an important role for endogenous opioids in adjustment to 
stress in this case of  PTSD. 
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INTRODUCTION 
Post-traumatic stress disorder (FIND) is a psychophysiologic disturbance 
that may arise following exposure to a traumatic event outside the range of 
usual human experience (American Psychiatric Association, 1987). Some of 
the characteristic symptoms of PTSD include, among others, reexperiencing 
the traumatic event(s), numbing of general responsiveness, periodic outbursts 
of anger, and increased arousal. Endogenous opioid peptides are released dur- 
ing intense stimulation and may be important in acute and chronic adaptation 
to traumatic stress (McCubbin, 1993). Van der Kolk and colleagues (1985) 
suggest that these neuropeptide systems may play a role in the development 
and maintenance of some of the characteristic symptoms of PTSD. 
Evidence of opioidergic mechanisms in PTSD derive from several 
lines of research. For example, animal studies indicate that inescapable 
stress produces several symptoms that resemble the pathologic profile of 
PTSD, including analgesia, hyperarousal, and decreased motivation (Van 
der Kolk et al., 1985). Moreover, pharmacologic blockade of endogenous 
opioid receptors prevents stress-induced analgesia as well as the perform- 
ance deficits that typically follow exposure to inescapable stress in rats 
(McCubbin et al., 1984). Similar effects have been observed in normal hu- 
man subjects experiencing a perceived uncontrollable stressor (Bandura 
et al., 1988). Recently, the link between opioids and PTSD has been more 
directly examined by administration of naloxone to combat veterans with 
PTSD (Pitman et al., 1990). Combat veterans with PTSD showed decreased 
pain sensitivity following exposure to a dramatized combat movie. These 
analgesic effects were blocked with the short-term opioid antagonist nalox- 
one, supporting the notion that endogenous opioids may be directly 
involved in the expression of FFSD symptomatology. 
Our laboratory has been systematically examining the role of opioids 
in the expression of individual differences in circulatory, neuroendocrine, 
and behavioral reactivity to stress in young adults (McCubbin et al., 1985; 
McCubbin et al., 1989). Using pharmacologic blockade of endogenous 
opioids with naloxone, these studies have suggested that opioids can inhibit 
cardiovascular, sympathoadrenomedullary, and pituitary-adrenocortical re- 
activity, and moreover, this opioidergic inhibitory mechanism is diminished 
in persons at risk for cardiovascular disease. This research has recently been 
expanded to studies of the effect of the long-lasting oral opioid antagonist, 
naltrexone, on laboratory reactivity (McCubbin et al., 1992) and 24-hr am- 
bulatory blood pressure patterns. We now report a case of an unusual 
behavioral and cardiovascular reaction during opioid blockade with naltrexone 
in a young adult male with a history of childhood abuse and military combat 
trauma who met DSM III-R criteria for PTSD. 
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METHODS 
The present case study resulted from a reaction to opioid blockade 
in one individual participating in a single-blind placebo-controlled inves- 
tigation of laboratory and ambulatory stress. Twenty-four subjects with 
mildly elevated blood pressures were recruited from an on-campus screen- 
ing similar to that described in McCubbin et  al. (1985). Male young adult 
volunteers with stable mean arterial pressures in the upper quintile of the 
distribution were scheduled for four in-laboratory psychological stress 
tests. Because of a related interest in ambulatory pressures, the long last- 
ing, oral opioid blocking drug naltrexone (Trexan, DuPont) was used. In 
the laboratory, subjects were fitted with an automated blood pressure cuff 
(Critikon, Tampa), and following a 10-min rest, blood pressures and heart 
rates were obtained. Subjects were then given either a 50 mg naltrexone 
tablet or a placebo (order was counterbalanced). Subjects rested for one 
hour and were then reinstrumented for blood pressure measurement. 
After a 10-min postdrug rest, participants then performed a difficult ten- 
minute arithmetic task (McCubbin et al., 1992), followed by a post stress 
recovery period. After the in-lab study, subjects were equipped with a 
Spacelabs 90202 ambulatory blood pressure monitor (Spacelabs Inc., 
Redmond, WA) and a diary for a 24-hr study during normal activity. Drug 
or placebo within-subject control experiments were scheduled about a 
week later. The protocol was approved by the University of Kentucky 
Medical Institutional Review Board and participants gave informed con- 
sent for the experimental protocol. 
RESULTS 
A 32-year-old male (Mr. B) reported an unusual set of reactions fol- 
lowing his second laboratory session, during which he had blindly received 
an oral 50 mg naltrexone tablet. Mr. B had received a placebo tablet dur- 
ing his initial visit to the laboratory, and that laboratory and ambulatory 
experience was unremarkable. Approximately one week later, Mr. B re- 
turned to the laboratory, received 50 mg naltrexone at 2:30 pm, and par- 
t icipated in the labora tory  session. At about  4:15 pm, Mr. B was 
instrumented for ambulatory monitoring, requested to record his activities 
and to return the equipment 24 hr later. Upon return to the laboratory 
the following day, Mr. B indicated that he had experienced some unusual 
symptoms. He was then referred for extended debriefing and psychological 
evaluation. 
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The following events and symptoms were reported by Mr. B during 
debriefing. Approximately 2 hr after administration of naltrexone, Mr. B left 
the laboratory and drove to visit his wife at a local business where they were 
both employed. On the way, he reported becoming aware that he was getting 
a headache and felt that something was "not quite right" with his visual per- 
ception. The onset of these symptoms was reported to be gradual. 
Upon arrival, he told his wife about his symptoms. As he was looking 
at her, he felt he was losing his depth perception; that is, he experience d 
the image of his wife as two-dimensional, like "an image on a mirror." He 
also experienced the image of his wife as somewhat distorted, which he de- 
scribed as similar to looking through a "carnival mirror." Furthermore, he 
noted difficulties focusing, and that his vision appeared to be "skewed" to 
his right. According to Mr. B, his wife was amused by the explanation of 
his symptoms and began to jokingly move her head from side to side. This 
made him "very upset" and as a result he "grabbed" her and told her "don't 
do that anymore." Subsequently, he noticed the owner watching him "with 
a strange look." Mr. B then became angrier and accused his wife of not 
caring that he had a headache and not "paying attention" to him. At that 
point, he angrily knocked down several boxes. He then noticed his headache 
was dissipating and his visual distortions had disappeared though he re- 
mained angry. His wife proceeded back to the stockroom where he followed 
her while enraged "at her behavior." Shortly after, he returned to the front 
of the store attempting to understand the source of his rage when he ob- 
served his ambulatory blood pressure cuff on the floor. He believes he took 
it off and dropped it while arguing with his wife. Subsequently, he left the 
store, sat in his car, and replaced his blood pressure cuff. While in the car, 
he noted that his anger was "turned off like a faucet." He then returned 
home and reported no further sequelae. 
Mr. B indicated that his behavior had been "very mean, yelling and 
screaming past the point of rage." He denied other incidents of similar 
behavior without significant provocation. He later reported that his angry 
response was totally out of proportion to what had occurred. Furthermore, 
he perceived his reaction as a loss of control which was both unfamiliar 
and disturbing. Mr. B denied taking alcohol or other drugs. He attributed 
his symptoms and his behavior to possible intake of naltrexone. 
Case History and Diagnosis 
Mr. B was reportedly diagnosed with dyslexia during the second 
grade, placed in special education classes, and was prescribed Valium for 
"hyperactivity." He reported that he and his 2 siblings were repeatedly 
Hosted in the Center for Research on Violence Against Women institutional repository with written permission from John Wiley & Sons, Inc.
Brief Report 307 
physically abused in childhood, including beatings, being locked in a closet 
for extended periods, and threats to his life. He reported suicidal ideation 
following these experiences. 
Mr. B enlisted in the Army following his high school graduation and 
remained in active service until shortly after his participation in a combat 
mission. He  indicated that during the mission he was almost shot and that 
he killed one person to save a friend. He said that he had not resolved 
his own feelings about having taken someone's life. 
Mr. B met the DSM-III-R (American Psychiatric Association, 1987) 
criteria for the diagnosis of PTSD. His history of parental abuse, and his 
experiences in combat represent events that are, in our judgment, outside 
the range of normal human experience. He presented with the following 
symptoms: persistent arousal, hypervigilance, intrusive recollections and 
nightmares, exaggerated startle responses to innocuous environmental stim- 
uli, avoidance  of  thoughts  associa ted with his t raumas,  difficulty 
remembering aspects of these events, identification with other victims of 
trauma, detachment from significant others, and a sense of foreshortened 
future. 
Cardiovascular Data 
Mr. B's resting diastolic pressures in the laboratory prior to admini- 
stration of naltrexone were not significantly different from the group av- 
erage (Mr. B = 73.6 mm Hg versus group mean = 75 + 3.41 SD). In 
contrast, however, his resting in-lab systolic pressure was significantly 
lower than the group average (Mr. B = 108 mm Hg versus group average 
123.2 + 7.25, z = 2.10, p < 0.05). Mr. B's blood pressure responses to 
arithmetic stress were not different from the group average following pla- 
cebo administration. 
Administration of naltrexone did not significantly affect his resting 
pressures in the laboratory. However, naltrexone produced increases in 
blood pressure reactivity during and after stress and these effects were sig- 
nificantly greater than the group averages. For example, the drug effect on 
Mr. B's diastolic reactivity was significantly greater than the group average 
in the second 5 minute block of arithmetic stress (z = 2.53, p < 0.025) 
and during both the first (z = 3.04, p = 0.0025) and second (z -- 2.23, 
p < 0.05) five-minute blocks of recovery from stress. Naltrexone also in- 
creased Mr. B's ambulatory blood pressures during the 24-hr period 
immediately following his laboratory sessions. For example, his 24-hr aver- 
age ambulatory blood pressures were 123/73 mm Hg following placebo, and 
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130/80 following naltrexone (t(36) = 5.83, p < 0.001 for systolic, t(36) = 
6.21, p < 0.001 for diastolic). There were also effects of naltrexone on 
acute ambulatory pressor responses. While there were no systolic readings 
above 140 mm Hg during the placebo period, 22.7% of systolic readings 
were above 140 mm Hg during the naltrexone period. For ambulatory dia- 
stolic pressures, 6.7% of readings were above 90 mm Hg during the placebo 
period, but 18.2% of diastolic readings were above 90 mm Hg during the 
naltrexone period. 
DISCUSSION 
The present case study demonstrates an unusual reaction to phar- 
macologic blockade of opioid receptors with naltrexone in a case of post- 
traumatic stress disorder. Data from an extensive clinical evaluation 
indicates that Mr. B clearly met the DSM III-R criteria for PTSD and 
he acknowledged this diagnosis. He added that he had not previously 
sought treatment of his disorder for fear of being stigmatized and had 
underreported the severity of his symptoms to military personnel and to 
counselors. 
If endogenous opioids are important in adaptation to repeated 
trauma, then it is possible that blockade of these adaptive mechanisms 
could precipitate significant psychological distress. In the present case, 
naltrexone administration evoked hypervigilance and anger outbursts, 
both of these symptoms are included in the DSM-III-R (American Psy- 
chiatric Press, 1987) criteria for PTSD. The relationship between opioids 
and other unusual symptoms such as dissociative phenomena requires 
further investigation. Mr. B's reported history of developmental hyper- 
activity and dyslexia could not  be confirmed.  It remains unknown 
whether the history of these disorders contributed to Mr. B's reaction 
to naltrexone. 
Some of the symptoms of PTSD may reflect underlying psychobiologic 
mechanisms similar to exogenous opiate withdrawal phenomena (Van der 
Kolk et al., 1985). Pharmacologic opioid blockade can precipitate with- 
drawal in opiate dependency, and the present case could reflect similar 
endogenous phenomena. Exaggerated blood pressure reactivity is also typi- 
cal of opiate withdrawal, further strengthening the conceptual similarities 
between the present results, exogenous opiate withdrawal, and PTSD. 
Moreover, the antihypertensive medication clonidine eases opiate with- 
drawal symptoms and may also be effective in t rea tment  of PTSD 
hyperreactivity (Gold et al., 1978; Kolb et al., 1984). 
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While the present case study results cannot be definitively ascribed 
to administration of naltrexone, both the blood pressure and behavioral 
responses following ingestion of  naltrexone are consistent with a role of 
endogenous opioids in acute and chronic adjustment to stress in this case 
of PTSD. Therefore, more research is needed on the role of  endogenous 
opioids in PTSD, hut it is also recommended that opioid receptor blockade, 
especially with naltrexone, be utilized with caution in persons with a history 
of trauma. 
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